WhatsApp · 24/7 English Support
Cancer Therapy · Treatment List

Treatment List · Diseases We Coordinate Care For

A curated overview of the diseases treated by our partner clinical centres within GoBroad Healthcare Group — spanning solid tumors, blood diseases, paediatric oncology, autoimmune disease and neurological disorders, together with the advanced treatment options and lead expert teams for each area.

GoBroad International Medical Center

Center for the Diagnosis & Treatment of Complex, Relapsed and Refractory Diseases

Focus Areas

Hematologic Diseases

  • Leukemia
  • Lymphoma
  • Multiple Myeloma
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Rare Immunodeficiency Disorders

Solid Tumors

  • Gastrointestinal Cancers (Esophageal, Gastric, Colorectal, Hepatopancreatobiliary)
  • Thoracic Tumors (Lung, Breast)
  • Bone & Soft-Tissue Tumors
  • Intracranial Tumors
  • Melanoma & Genitourinary Cancers

Brain Sciences

  • Parkinson's Disease
  • Essential Tremor
  • Cognitive Disorders & Other Chronic Neurological Diseases

Advanced Treatment Technologies

  • CAR-T Cell Therapy

    Focused on relapsed / refractory hematologic malignancies

  • CAR-NK & NK Cell Therapy

    Cutting-edge immunotherapy strategies

  • Hematopoietic Stem Cell Transplantation

    Tailored strategies for elderly and high-risk patients

  • Gene Therapy

    Targeting specific genetic and tumor-related diseases

  • Proton Therapy

    Precision radiotherapy minimizing damage to normal tissue

  • Deep Brain Stimulation (DBS)

    For Parkinson's disease and other neurological disorders

  • MRI-Guided Focused Ultrasound (MRgFUS)

    Non-invasive, high-precision brain treatment

Why Choose Us

  • Expertise in Refractory & Relapsed Disease

    Extensive clinical experience where standard therapies have failed.

  • Leadership in Cell Therapy

    Established platforms and mature clinical systems in CAR-T and other cellular immunotherapies.

  • Multidisciplinary Team (MDT)

    Chemotherapy, targeted therapy, immunotherapy, radiotherapy, interventional therapy and surgery — tailored to each case.

  • Precision Medicine

    Genomic profiling (e.g. NGS) for precise stratification and individualized treatment.

  • Integrated Care Continuum

    Comprehensive coverage from diagnosis to treatment and follow-up.

  • International Patient Services

    End-to-end support including remote consultation, cross-border referral and full-cycle management.

01

Solid Tumor

Diseases

Gastrointestinal Tumor

  • Gastric Cancer
  • Colorectal Cancer
  • Esophageal Cancer
  • Pancreatic Cancer
  • Gastrointestinal Stromal Tumor (GIST)
  • Neuroendocrine Tumor
  • Biliary Cancer
  • Liver Cancer

Thoracic Tumor

  • Lung Cancer
  • Breast Cancer

Bone & Soft Tissue Sarcoma

  • Bone Tumors: Osteosarcoma, Ewing Sarcoma, Chondrosarcoma, Giant Cell Tumor of Bone
  • Soft Tissue Tumors: Liposarcoma, Leiomyosarcoma, Fibrosarcoma, Rhabdomyosarcoma, Malignant Fibrous Histiocytoma

Advanced Treatment Options

  • New Drugs
  • Clinical Trials
  • Cell Therapy (CAR-T, TIL, NK, CIK)
  • Nuclear Medicine Therapy
  • MDT one-stop comprehensive management (bone & soft tissue sarcoma)

Advantages

  • Expert Team
  • One-stop MDT comprehensive cancer treatment
  • New drugs, new technologies and advanced equipment
  • Active clinical trial programmes

Lead Expert Team

Lin SHENMing LUZhi PENGChangsong QIJin LIJun ZHOUJiaqing XIANGYingqi ZHOUHaifeng QINLili QINShasha WANGBaohui HANShuang LIWei ZHAOYang YAOMing GUAN
02

Blood Disease

Diseases

Leukemia

  • Acute B-lymphoblastic Leukemia (B-ALL)
  • Acute T-lymphoblastic Leukemia (T-ALL)
  • Acute Myeloid Leukemia (AML)
  • Chronic Lymphocytic Leukemia (CLL)
  • Mixed Phenotype Acute Leukemia (MPAL)
  • Acute Promyelocytic Leukemia (APL)
  • Acute Undifferentiated Leukemia (AUL)
  • Plasma Cell Leukemia
  • Juvenile Myelomonocytic Leukemia (JMML)
  • Other rare types of leukemia

Lymphoma

  • Diffuse Large B-cell Lymphoma (DLBCL)
  • Primary Central Nervous System Lymphoma (PCNSL)
  • Primary Mediastinal Large B-cell Lymphoma
  • Follicular Lymphoma
  • Richter's Syndrome
  • T-lymphoblastic Leukemia / Lymphoma
  • Peripheral T-cell Lymphoma
  • Lymphoblastic Lymphoma
  • Burkitt Lymphoma
  • Anaplastic Large Cell Lymphoma (ALCL)
  • Peripheral T/NK-cell Lymphoma
  • Hodgkin Lymphoma
  • Marginal Zone Lymphoma
  • Subcutaneous Panniculitis-like T-cell Lymphoma (SPTCL)
  • Other rare types of lymphoma

Myeloma

  • Refractory Multiple Myeloma

Other Blood Diseases

  • Thalassemia (TDT)
  • Sickle Cell Disease (SCD)

Advanced Treatment Options

  • Cell Therapy (CAR-T, TIL)
  • Antibody Therapy
  • Targeted Drugs
  • Hematopoietic Stem Cell Transplantation (HSCT)
  • Gene Diagnosis and Treatment

Advantages

  • Internationally recognised medical team with strong clinical & research capability
  • Precision diagnosis and integrated treatment for improved outcomes
  • Multidisciplinary one-stop diagnostic and treatment services
  • Cutting-edge CAR-T, NGS-guided targeted therapy and HSCT for refractory / relapsed disease

Lead Expert Team

Chunrong TONGShuangyou LIUDefeng ZHAOYajing ZHANGYonghong ZHANGKai WANGYing LIUXiaoyan KEKai HUFan YANG
03

Pediatrics

Diseases

Pediatric Blood Disease

  • Refractory / relapsed pediatric lymphomas (Lymphoblastic, Burkitt, ALCL, Peripheral T/NK-cell, Hodgkin, Follicular, Marginal Zone, SPTCL)
  • Pediatric Leukemias: ALL, AML, Chronic Leukemia, MPAL, Myeloid Sarcoma, rare types
  • Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
  • Lymphoproliferative Disorders
  • Hereditary Hematologic Disorders
  • Hemophagocytic Lymphohistiocytosis (HLH)
  • Myelodysplastic Syndrome (MDS)
  • Bone Marrow Failure Disorders
  • Langerhans Cell Histiocytosis (LCH)
  • Thalassemia

Pediatric Solid Tumor

  • Neuroblastoma
  • Rhabdomyosarcoma
  • Other pediatric solid tumors

Advanced Treatment Options

  • Single- or multi-target sequential CAR-T therapy
  • Autologous / allogeneic CAR-T bridging HSCT
  • NGS-guided precision targeted therapy
  • Combination of targeted drugs, antibody therapy and chemotherapy

Advantages

  • Accurate diagnosis and refined stratified treatment — higher cure rates for newly diagnosed patients
  • CAR-T for refractory / relapsed hematologic malignancies with high remission rates and enhanced safety
  • Combination strategies delivering excellent short-term efficacy and long-term quality of life

Lead Expert Team

Yonghong ZHANGKai WANGYing LIUChunfu LIYuelin HEChunrong TONGShuangyou LIU
04

Autoimmune Diseases

Diseases

  • Sjögren's Syndrome
  • Systemic Lupus Erythematosus (SLE)
  • Rheumatoid Arthritis (RA)
  • Multiple Sclerosis (MS)
  • Type 1 Diabetes
  • Myasthenia Gravis
  • Crohn's Disease
  • Pemphigus Vulgaris
  • Mixed Connective Tissue Disease (MCTD)

Advanced Treatment Options

  • Antibody drugs, immunosuppressants, immunoregulation, plasmapheresis and symptomatic therapy
  • CAR-T cell immunotherapy

Advantages

  • Combination of cellular immunotherapy and traditional treatment

Lead Expert Team

Yajing ZHANGJingyu JIN
05

Neurological Disorders

Diseases

  • Parkinson's Disease (PD)
  • Essential Tremor (ET)

Advanced Treatment Options

  • DBS (Deep Brain Stimulation) for primary, genetic and various genotypes of PD
  • MRgFUS (Magnetic Resonance Guided Focused Ultrasound) — non-invasive, no craniotomy, no general anaesthesia, no implanted hardware, no ionising radiation; patient remains conscious throughout

Advantages

  • Multidisciplinary team
  • Combination of medication and surgery

Lead Expert Team

Biao CHENZhipei LINGXin YU

Free Case Feasibility Assessment

Start your medical journey to China

Based in Hong Kong and serving international patients, Privilege Medical bridges you to leading Class 3A and JCI-accredited hospitals in mainland China. We do not provide medical care directly — we coordinate specialist matching, medical visa support and on-the-ground concierge from your first enquiry to post-treatment follow-up.

Complete the form below. Our coordination team responds within 1–2 business days with a complimentary assessment covering clinical feasibility, specialist matching and an indicative admission timeline.

Supporting Documents (Optional)

Attach each document below, or tick "Send later" and email it to us afterwards. Accepted formats: PDF, JPG, PNG, DICOM (.dcm), ZIP.

Treatment History

Past therapies, surgeries, medications and dates.

Medical Report

Discharge summaries, pathology, lab results.

Imaging Report

CT, MRI, PET, X-ray files or written reports.

service@privilegemedical.comWhatsApp +852 84006118

Privacy Notice

Privilege Medical is a Hong Kong–based medical concierge and does not provide clinical care. Personal data and medical information you submit are collected, held and used strictly for the purposes of case assessment, specialist matching and coordination of medical services in mainland China, in accordance with the Personal Data (Privacy) Ordinance (Cap. 486) of Hong Kong.

Your data may be transferred to our partner hospitals, treating clinicians and authorised service providers (including translators and travel coordinators), some of whom are located outside Hong Kong. We take reasonable steps to keep your information confidential and secure, and we do not sell your data to any third party.

You have the right, under the PDPO, to request access to and correction of the personal data we hold about you, and to withdraw consent at any time by writing to service@privilegemedical.com. Information submitted via this form is not encrypted end-to-end; please avoid including highly sensitive identifiers (e.g. ID numbers) in the free-text fields.